Five patients undergoing 7 axillary hidradenitis reconstruction procedures were eligible for inclusion after applying the exclusion and inclusion criteria (Table). At the time of the operation, the average patient age was 18.2 years (range, 14.8–20.9 years). All patients were female. The average body mass index was 33.0 kg/m2 (range, 27.0–37.2 kg/m2). No patient had any medical comorbidities that would affect wound healing or skin graft take. Four patients had undergone an average of 1.4 incision and drainage procedures (range, 1–3 procedures) prior to reconstruction. After DRT placement, the average length of hospital stay was 1.6 days (range, 1–3 days) for pain control. Patients underwent an average of 4.9 NPWT changes (range, 3–8 changes) prior to final skin grafting for each reconstruction, with an average of 27.7 days (range, 23–36 days) between DRT placement and skin grafting. Total morphine equivalents (MEqs) consumed during admission were 61.2 MEq for excision and DRT placement (range, 13.9–254 MEq) and 35.9 MEq for skin grafting (range, 19–79 MEq). No patients had any recorded complications, including infection, DRT loss, or full or partial skin graft loss. For all patients, axillary range of motion was explicitly noted to be full at the final follow-up visit. No recurrence of hidradenitis was noted in any of the surgically managed axillae. Time to final follow-up averaged 273.4 days from final skin grafting (range, 38–546 days).
Wounds. 2022;34(2):43-46. © 2022 HMP Communications, LLC